Abstract | BACKGROUND: METHODS: CONCLUSION: We conclude that the application of subcutaneous immunoglobulin is easy to learn, helps to reduce in-hospital costs and enables a more flexible everyday life. The treatment with subcutaneous immunoglobulin helps to reduce immunosuppressants and appears to prevent relapses.
|
Authors | Ilka Kleffner, Jan Dörr, Thomas Duning, Peter Young, E Bernd Ringelstein, Matthias Schilling |
Journal | European neurology
(Eur Neurol)
Vol. 71
Issue 1-2
Pg. 89-92
( 2014)
ISSN: 1421-9913 [Electronic] Switzerland |
PMID | 24335148
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Immunoglobulins
- Immunologic Factors
|
Topics |
- Female
- Humans
- Immunoglobulins
(administration & dosage, therapeutic use)
- Immunologic Factors
(administration & dosage, therapeutic use)
- Infusion Pumps, Implantable
- Infusions, Subcutaneous
- Self Administration
- Susac Syndrome
(diagnosis, therapy)
- Treatment Outcome
- Young Adult
|